Response to Wagner et al.: phosphodiesterase-2-anti-adrenergic friend or hypertrophic foe in heart disease?

Naunyn Schmiedebergs Arch Pharmacol. 2016 Nov;389(11):1143-1145. doi: 10.1007/s00210-016-1301-z. Epub 2016 Sep 27.

Authors

Anna Zoccarato¹, Laura H Fields², Manuela Zaccolo³

Affiliations

¹ Department of Cardiology, Cardiovascular Division, British Heart Foundation Centre, King's College London, London, UK.
² Translational Medicine and Therapeutics, John Vane Science Centre, Charterhouse Square, Queen Mary University of London, London, UK.
³ Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK. [email protected].

No abstract available

Publication types

Editorial

MeSH terms

Adrenergic Antagonists*
Heart Diseases*
Humans
Hypertrophy
Phosphoric Diester Hydrolases

Substances

Adrenergic Antagonists
Phosphoric Diester Hydrolases

Grants and funding